Flow cytometric studies of IL-4-stimulated expression of the CD25 antigen by quiescent human B lymphocyte subpopulations.
- 1 November 1991
- journal article
- Vol. 74 (3) , 511-8
Abstract
The membrane immunoglobulin (mIg) phenotype of high-density human tonsillar B lymphocytes which display elevated levels of the CD25 marker in response to treatment with interleukin-4 (IL-4) has been investigated. IL-4 promotes elevation of CD25 levels in B lymphocytes expressing membrane IgM (mIgM), mIgD, mIgG and mIgA. Three-colour flow cytometric analyses indicate that 25-35% of high-density tonsillar B cells are simultaneously positive for mIgM, mIgD and CD25 following IL-4 stimulation. The hypothesis that B cells could respond to IL-4 by up-regulation of either CD23 or CD25, but not both simultaneously, was evaluated. Three-colour flow cytometric studies indicated that approximately one-third of the B-lymphocyte population was simultaneously positive for the CD19, CD23 and CD25 antigens following stimulation with IL-4. These data are consistent with the proposal that IL-4 can promote expression of CD23 and CD25 antigens in the same B lymphocyte.This publication has 34 references indexed in Scilit:
- Cross‐talk between B cell surface immunoglobulin and interleukin 4 receptors: the role of protein kinase C and Ca2+‐mediated signalsEuropean Journal of Immunology, 1990
- HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprisesImmunology Today, 1989
- Interleukin-2 Receptor β Chain Gene: Generation of Three Receptor Forms by Cloned Human α and β Chain cDNA'sScience, 1989
- Mechanism of Interleukin-2 Signaling: Mediation of Different Outcomes by a Single Receptor and Transduction PathwayScience, 1989
- The effect of recombinant interleukin 4 upon protein kinase activities associted with murine and human B lymphocyte plasma membranesCellular Signalling, 1989
- A role for human heavy chain binding protein in the developmental regulation of immunoglobin transportMolecular Immunology, 1988
- Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assaysEuropean Journal of Immunology, 1987
- T cell help in human antigen‐specific antibody responses can be replaced by interleukin 2European Journal of Immunology, 1986
- The roles of interleukin 2 and interferon‐γ in human B cell activation, growth and differentiationEuropean Journal of Immunology, 1986
- H‐2‐restricted T‐B cell interactions involved in polyspecific B cell responses mediated by soluble antigenEuropean Journal of Immunology, 1982